Successful treatment sequence incorporating bevacizumab for therapy of polyneuropathy in two patients with POEMS syndrome

Leukemia Research

Volumn 36, Issue 5, 2012, Pages

  Buxhofer Ausch, Veronika ^a,b   Gisslinger, Bettina ^b   Stangl, Gerhard ^a   Rauschka, Helmut ^c   Gisslinger, Heinz ^c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Ludwig Boltzmann Society   (Austria)

^c Department of Nuclear Medicine ^*  (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CYCLOPHOSPHAMIDE; DEXAMETHASONE; LENALIDOMIDE; VASCULOTROPIN;

ADULT; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; BONE MARROW BIOPSY; CANCER RADIOTHERAPY; CASE REPORT; DRUG DOSE SEQUENCE; DRUG MEGADOSE; DRUG TOLERABILITY; FEMALE; HEPATOSPLENOMEGALY; HUMAN; HYPOGONADISM; KARNOFSKY PERFORMANCE STATUS; LETTER; LYMPHADENOPATHY; MALE; MULTIPLE CYCLE TREATMENT; OSTEOLYSIS; PARAPROTEINEMIA; PHYSIOTHERAPY; PLASMACYTOMA; POEMS SYNDROME; POLYNEUROPATHY; PRIORITY JOURNAL; PROTEIN BLOTTING; RADIOGRAPHY; SENSORIMOTOR NEUROPATHY;

ADULT; ANTIBODIES, MONOCLONAL, HUMANIZED; FEMALE; HUMANS; MALE; MIDDLE AGED; POEMS SYNDROME; POLYNEUROPATHIES; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84858747496     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2012.01.018     Document Type: Letter

References (12)

1. Dispenzieri A. POEMS syndrome. Blood Rev 2007, 21(6):285-299.
2. Dispenzieri A. POEMS syndrome. Hematology Am Soc Hematol Educ Program 2005, 360-367.
3. Dispenzieri A., Lacy M.Q., Hayman S.R., Kumar S.K., Buadi F., Dingli D., et al. Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome. Eur J Haematol 2008 May, 80(5):397-406.
4. Scarlato M., Previtali S.C., Carpo M., Pareyson D., Briani C., Del Bo R., et al. Polyneuropathy in POEMS syndrome: role of angiogenic factors in the pathogenesis. Brain 2005, 128:1911-1920.
5. Badros A., Porter N., Zimrin A. Bevacizumab therapy for POEMS syndrome. Blood 2005, 106(3):1135.
6. Straume O., Bergheim J., Ernst P. Bevacizumab therapy for POEMS syndrome. Blood 2006, 107(12):4972-4973. Author reply (including response from Badros Z, Jaccard A).
7. Dietrich P.Y., Duchosal M.A. Bevacizumab therapy before autologous stem-cell transplantation for POEMS syndrome. Ann Oncol 2008, 19(3):595.
8. Ohwada C., Nakaseko C., Sakai S., Takeda Y., Abe D., Takeuchi M., et al. Successful combination treatment with bevacizumab, thalidomide and autologous PBSC for severe POEMS syndrome. Bone Marrow Transplant 2009, 43(9):739-740.
9. Kanai K., Kuwabara S., Misawa S., Hattori T. Failure of treatment with anti-VEGF monoclonal antibody for long-standing POEMS syndrome. Intern Med 2007, 46(6):311-313.
10. Samaras P., Bauer S., Stenner-Liewen F., Steiner R., Zweifel M., Renner C., et al. Treatment of POEMS syndrome with bevacizumab. Haematologica 2007, 92(10):1438-1439.
11. Richardson P.G., Schlossman R.L., Weller E., Hideshima T., Mitsiades C., Davies F., et al. Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma. Blood 2002, 100(9):3063-3067.
12. Sethi S., Tageja N., Arabi H., Penumetcha R. Lenalidomide therapy in a rare case of POEMS syndrome with kappa restriction. South Med J 2009, 102(10):1092-1093.